Achieve Life near FDA approval of smoking addiction treatment, Hunterbrook says

Achieve Life Sciences (ACHV) is close to gaining FDA approval of cytisinicline as a safe, effective treatment for smoking addiction, Hunterbrook’s Nathaniel Horwitz, Laura Wadsten, and Michelle Cera report. The FDA has previously accepted the company’s anti-smoking application for review following two successful Phase 3 clinical trials as well as a successful longer-term safety study, the authors note.